Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hip Replacement System Minimizes Dislocation

By HospiMedica staff writers
Posted on 20 Sep 2006
A new total hip replacement system has been designed to help minimize dislocation and its associated healthcare costs, while providing an alternative to metal-on-metal bearings. More...


The Trident polyethylene hip system uses low friction ion treatment (LFIT) anatomic femoral heads with X3 polyethylene liners. LFIT technology is a bombardment of nitrogen ions onto a cobalt-chrome (CoCr) surface, which enhances the material properties of the metal, in turn reducing frictional forces against ultra-high molecular weight polyethylene (UHMWPE) surfaces. The treatment provides improved wettability and reduces the coefficient of friction.

The X3 polyethylene liners are composed of highly crosslinked polyethylene, manufactured in a third-generation annealing process with three sequential irradiation/annealing steps that provide a structural fatigue strength better than conventional polyethylene, a 97% reduction in wear over conventional polyethylene, and oxidation resistance similar to virgin polyethylene.

The new Trident hip system is a product of Stryker (Kalamazoo, MI, USA), and offers superior locking mechanisms, a choice of shell geometries, eccentric and constrained inserts for revision options, and is anatomically sized for more-natural hip performance. The system has been approved by the U.S. Food and Drug Administration (FDA).

"Up until now, metal on metal options in larger sizes only met the needs of a subset of the total hip population. We are excited that anatomic heads with X3 liners will help post- operative orthopedic patients achieve their lifestyle recovery objectives,” said Mike Mogul, president of Stryker Orthopaedics.



Related Links:
Stryker

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.